ELAC2 and Prostate Cancer, Hereditary, 2: Association Evidence

In brief

The association between ELAC2 (ElaC Ribonuclease Z 2) and Prostate Cancer, Hereditary, 2 is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording a known molecular basis, pathogenic variants, causative variation, and a susceptibility locus.

At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access

Provenance

Evidence and sources

4 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access

ELAC2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access

Prostate Cancer, Hereditary, 2

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access

ClinVar and variant evidence

Genetic basis

40 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access

Literature

Reading

5 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access

Provenance

References & sources

10 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access